CN Patent

CN103476752B — 取代的芳香族硫化合物及其使用方法

Assigned to Safran SA · Expires 2016-09-28 · 10y expired

What this patent protects

本发明描述了式II的化合物，以及药物组合物和使用式II的化合物在患者中治疗腹膜癌转移或降低腹膜癌转移风险的方法，其中D、n、R a 、R b 和R c 如本文中所定义：

USPTO Abstract

本发明描述了式II的化合物，以及药物组合物和使用式II的化合物在患者中治疗腹膜癌转移或降低腹膜癌转移风险的方法，其中D、n、R a 、R b 和R c 如本文中所定义：

Drugs covered by this patent

ruxolitinib-phosphate (RUXOLITINIB PHOSPHATE)

Patent Metadata

Patent number: CN103476752B
Jurisdiction: CN
Classification: —
Expires: 2016-09-28
Drug substance claim: No
Drug product claim: No
Assignee: Safran SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.